Portal de Periódicos da CAPES

Neuroprotection in the SAINT‐II aftermath

2007; Wiley; Volume: 62; Issue: 6 Linguagem: Inglês

10.1002/ana.21210

1531-8249

Dirk M. Hermann, Claudio L. Bassetti,

Neuroinflammation and Neurodegeneration Mechanisms

Annals of NeurologyVolume 62, Issue 6 p. 677-678 Letters and Replies Neuroprotection in the SAINT-II aftermath Dirk M. Hermann MD, Dirk M. Hermann MD Department of Neurology, University Hospital Zurich, Zurich, SwitzerlandSearch for more papers by this authorClaudio L. Bassetti MD, Claudio L. Bassetti MD Department of Neurology, University Hospital Zurich, Zurich, SwitzerlandSearch for more papers by this author Dirk M. Hermann MD, Dirk M. Hermann MD Department of Neurology, University Hospital Zurich, Zurich, SwitzerlandSearch for more papers by this authorClaudio L. Bassetti MD, Claudio L. Bassetti MD Department of Neurology, University Hospital Zurich, Zurich, SwitzerlandSearch for more papers by this author First published: 11 September 2007 https://doi.org/10.1002/ana.21210Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Savitz SI, Fisher M. Future of neuroprotection in the aftermath of the SAINT trials. Ann Neurol 2007; 61: 396– 402. 2 Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U. SAINT II Trial Investigators. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007; 357: 562– 571. 3 Lees KR, Zivin JA, Ashwood T, et al, Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N Engl J Med 2006; 354: 588– 600. 4 Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30: 2752– 2758. 5 Hermann DM, Bassetti CL. Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol Sci 2007; 28: 128– 134. Citing Literature Volume62, Issue6December 2007Pages 677-678 ReferencesRelatedInformation